Aztreonam with avibactam
General Information
Monobactam and beta-lactamase inhibitor antibiotic
In patients with a history of penicillin or cephalosporin allergy, aztreonam may be administered without prior testing unless there is a history of ceftazidime allergy where allergy testing would be required.
Restricted formulary antimicrobial: For details see OUH netFormulary
AWaRe antibiotic classification: All indications to be discussed with Micro/ID. Has not been classified in 2025 UK modified AWaRe list.
Note: There is an EPR powerplan associated with this drug.
For all information regarding interactions, contraception, pregnancy and breastfeeding and additional information, see BNF and Summary of Product Characteristics (SPC).
Standard dose
| Intravenous dose | |
| Standard dose |
Loading dose: 2.7g (2g aztreonam / 677mg avibactam) single dose followed 6 hours later by Maintenance dose: 2g (1.5g aztreonam / 500mg avibactam) QDS |
- Each vial contains 1.5g aztreonam + 0.5g avibactam
- Standard maintenance dose of 2g (1.5g aztreonam + 0.5g avibactam) is 1 vial
Obesity
No dose adjustment required.
Renal and hepatic impairment
Renal impairment
| Creatinine Clearance (mL/min)* | Dose |
| 51 and above |
Dose as in normal renal function |
| 30 - 50 |
Loading dose: 2.7g (2g aztreonam / 677mg avibactam) single dose followed 6 hours later by Maintenance dose: 1g (750mg aztreonam / 250mg avibactam) QDS |
| 16 - 29 |
Loading dose: 1.8g (1.35g aztreonam / 450mg avibactam) single dose followed 8 hours later by Maintenance dose: 900mg (675mg aztreonam / 225mg avibactam) TDS |
|
15 or less and on HD/HDF/High flux or PD |
Discuss with pharmacy |
*dose ranges use creatinine clearance, rather than eGFR
Hepatic impairment
No dose adjustment required.
References
- Pfizer Limited. Summary of Product Characteristics (SPC). Emblaveo 1.5 g/0.5 g powder for concentrate for solution for infusion. Last revision of the text: 03/2025. Accessed via www.medicines.org.uk Accessed 08/09/2025
- BNF online accessed via www.medicinescomplete.com Accessed 08/09/2025
- The Renal Drug Database. EMBLAVEO (aztreonam/avibactam sodium). [online]. Last updated: 27/05/2025. Accessed via https://renaldrugdatabase.com Accessed 08/09/2025